BioNTech SE ADR Advances 4.7%, Outperforms Market

Dow Jones
15小時前

This article was automatically generated by Dow Jones using technology from Automated Insights.

The BioNTech SE ADR advanced 4.7% to $114.77 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.1% to 5,842.63 and the Dow Jones Industrial Average rising 1.1% to 43,006.59.

The ADR's rise snapped a two-day losing streak.

BioNTech SE ADR closed 12.7% short of its 52-week high of $131.49, which the company achieved on September 17th.

Trading volume totaled 662,908, compared to the 50-day average of 718,946.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

March 05, 2025 16:35 ET (21:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10